Engineered M13 Bacteriophage Nanocarriers for Intracellular Delivery of Exogenous Proteins to Human Prostate Cancer Cells

Bioconjugate Chemistry

Volumn 25, Issue 9, 2014, Pages 1620-1625

  DePorter, Sandra M ^a   McNaughton, Brian R ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGES; CELL CULTURE; CELLS; DISEASES; MOLECULAR BIOLOGY; UROLOGY;

CANCER CELL LINES; ENERGY; FOLDINGS; HUMAN PROSTATE CANCER CELLS; INTRACELLULAR DELIVERY; M13 BACTERIOPHAGE; NANOCARRIERS; PROSTATE CANCER CELLS; SMALL MOLECULES; WELL-DEFINED STRUCTURES;

PROTEINS;

HYBRID PROTEIN; NANOCARRIER; SAV GFP FUSION PROTEIN; UNCLASSIFIED DRUG; CAPSID PROTEIN; NANOMATERIAL; PROTEIN;

ARTICLE; BACTERIOPHAGE; BIOENGINEERING; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; PROSTATE CANCER CELL LINE; AMINO ACID SEQUENCE; CHEMISTRY; ENTEROBACTERIA PHAGE M13; GENETIC ENGINEERING; GENETICS; INTRACELLULAR SPACE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BACTERIOPHAGE M13; CAPSID PROTEINS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GENETIC ENGINEERING; HUMANS; INTRACELLULAR SPACE; MALE; MOLECULAR SEQUENCE DATA; NANOSTRUCTURES; PROSTATIC NEOPLASMS; PROTEINS;

EID: 84927516209     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc500339k     Document Type: Article

References (46)

1. Carter, P. J. (2011) Introduction to current and future protein therapeutics: a protein engineering perspective Exp. Cell Res. 317, 1261 - 9
2. Leader, B., Baca, Q. J., and Golan, D. E. (2008) Protein therapeutics: a summary and pharmacological classification Nat. Rev. Drug Discovery 7, 21 - 39
3. Feramisco, J. R., Gross, M., Kamata, T., Rosenberg, M., and Sweet, R. W. (1984) Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells Cell 38, 109 - 17
4. Gregoriadis, G. (1995) Engineering liposomes for drug delivery: progress and problems Trends Biotechnol. 13, 527 - 37
5. Zelphati, O., Wang, Y., Kitada, S., Reed, J. C., Felgner, P. L., and Corbeil, J. (2001) Intracellular delivery of proteins with a new lipid-mediated delivery system J. Biol. Chem. 276, 35103 - 10
6. Utama, R. H., Guo, Y., Zetterlund, P. B., and Stenzel, M. H. (2012) Synthesis of hollow polymeric nanoparticles for protein delivery via inverse miniemulsion periphery RAFT polymerization Chem. Commun. 48, 11103 - 5
7. Gabel, C. A. and Foster, S. A. (1986) Mannose 6-phosphate receptor-mediated endocytosis of acid hydrolases: internalization of beta-glucuronidase is accompanied by a limited dephosphorylation J. Cell Biol. 103, 1817 - 27
8. Fuchs, S. M. and Raines, R. T. (2005) Polyarginine as a multifunctional fusion tag Protein Sci. 14, 1538 - 44
9. Fuchs, S. M. and Raines, R. T. (2007) Arginine grafting to endow cell permeability ACS Chem. Biol. 2, 167 - 70
10. Cronican, J. J., Beier, K. T., Davis, T. N., Tseng, J. C., Li, W., Thompson, D. B., Shih, A. F., May, E. M., Cepko, C. L., Kung, A. L., Zhou, Q., and Liu, D. R. (2011) A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo Chem. Biol. 18, 833 - 8
11. Cronican, J. J., Thompson, D. B., Beier, K. T., McNaughton, B. R., Cepko, C. L., and Liu, D. R. (2010) Potent delivery of functional proteins into Mammalian cells in vitro and in vivo using a supercharged protein ACS Chem. Biol. 5, 747 - 52
12. McNaughton, B. R., Cronican, J. J., Thompson, D. B., and Liu, D. R. (2009) Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins Proc. Natl. Acad. Sci. U.S.A. 106, 6111 - 6
13. Thompson, D. B., Cronican, J. J., and Liu, D. R. (2012) Engineering and identifying supercharged proteins for macromolecule delivery into mammalian cells Methods Enzymol. 503, 293 - 319
14. Deshayes, S., Morris, M. C., Divita, G., and Heitz, F. (2005) Cell-penetrating peptides: tools for intracellular delivery of therapeutics Cell. Mol. Life Sci. 62, 1839 - 49
15. Teicher, B. A. and Chari, R. V. (2011) Antibody conjugate therapeutics: challenges and potential Clin. Cancer Res. 17, 6389 - 97
16. Niesner, U., Halin, C., Lozzi, L., Gunthert, M., Neri, P., Wunderli-Allenspach, H., Zardi, L., and Neri, D. (2002) Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides Bioconjugate Chem. 13, 729 - 36
17. Muller, S., Zhao, Y., Brown, T. L., Morgan, A. C., and Kohler, H. (2005) TransMabs: cell-penetrating antibodies, the next generation Expert Opin. Biol. Ther. 5, 237 - 41
18. Alexis, F., Pridgen, E., Molnar, L. K., and Farokhzad, O. C. (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharmaceutics 5, 505 - 15
19. He, C., Hu, Y., Yin, L., Tang, C., and Yin, C. (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles Biomaterials 31, 3657 - 66
20. Merkel, T. J., Chen, K., Jones, S. W., Pandya, A. A., Tian, S. M., Napier, M. E., Zamboni, W. E., and DeSimone, J. M. (2012) The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles J. Controlled Release 162, 37 - 44
21. Wang, Y. A., Yu, X., Overman, S., Tsuboi, M., Thomas, G. J., and Egelman, E. H. (2006) The structure of a filamentous bacteriophage J. Mol. Biol. 361, 209 - 215
22. Smith, G. P. (1985) Filamentous fusion phage-novel expression vectors that display cloned antigens on the virion surface Science 228, 1315 - 1317
23. Smith, G. P. and Petrenko, V. A. (1997) Phage display Chem. Rev. 97, 391 - 410
24. Kim, K. P., Cha, J. D., Jang, E. H., Klumpp, J., Hagens, S., Hardt, W. D., Lee, K. Y., and Loessner, M. J. (2008) PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response Microb. Biotechnol. 1, 247 - 57
25. Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., and Discher, D. E. (2013) Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles Science 339, 971 - 5
26. Larocca, D., Burg, M. A., Jensen-Pergakes, K., Ravey, E. P., Gonzalez, A. M., and Baird, A. (2002) Evolving phage vectors for cell targeted gene delivery Curr. Pharm. Biotechnol. 3, 45 - 57
27. Dunn, I. S. (1996) Mammalian cell binding and transfection mediated by surface-modified bacteriophage lambda Biochimie 78, 856 - 61
28. Poul, M. A. and Marks, J. D. (1999) Targeted gene delivery to mammalian cells by filamentous bacteriophage J. Mol. Biol. 288, 203 - 11
29. Vaks, L. and Benhar, I. (2011) In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines J. Nanobiotechnol. 9, 58
30. Suthiwangcharoen, N., Li, T., Li, K., Thompson, P., You, S. J., and Wang, Q. (2011) M13 bacteriophage-polymer nanoassemblies as drug delivery vehicles Nano. Res. 4, 483 - 493
31. Li, K., Chen, Y., Li, S. Q., Huong, G. N., Niu, Z. W., You, S. J., Mello, C. M., Lu, X. B., and Wang, Q. A. (2010) Chemical modification of M13 bacteriophage and its application in cancer cell imaging Bioconjugate Chem. 21, 1369 - 1377
32. Bar, H., Yacoby, I., and Benhar, I. (2008) Killing cancer cells by targeted drug-carrying phage nanomedicines. BMC Biotechnol. 8, DOI: 10.1186/1472-6750-8-37.
33. Ghosh, D., Lee, Y., Thomas, S., Kohli, A. G., Yun, D. S., Belcher, A. M., and Kelly, K. A. (2012) M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer Nat. Nanotechnol. 7, 677 - 682
34. Ivanenkov, V. V. and Menon, A. G. (2000) Peptide-mediated transcytosis of phage display vectors in MDCK cells Biochem. Biophys. Res. Commun. 276, 251 - 257
35. Dickerson, T. J., Kaufmann, G. F., and Janda, K. D. (2005) Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy Expert Opin. Biol. Ther. 5, 773 - 781
36. Carrera, M. R. A., Kaufmann, G. F., Mee, J. M., Meijler, M. M., Koob, G. F., and Janda, K. D. (2004) Treating cocaine addiction with viruses Proc. Natl. Acad. Sci. U.S.A. 101, 10416 - 10421
37. Rakonjac, J., Jovanovic, G., and Model, P. (1997) Filamentous phage infection-mediated gene expression: construction and propagation of the gIII deletion mutant helper phage R408d3 Gene 198, 99 - 103
38. Ghosh, D., Kohli, A. G., Moser, F., Endy, D., and Belcher, A. M. (2012) Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery ACS Synth. Biol. 1, 576 - 582
39. Sidhu, S. S., Feld, B. K., and Weiss, G. A. (2007) M13 bacteriophage coat proteins engineered for improved phage display Methods Mol. Biol. 352, 205 - 19
40. DePorter, S. M., Lui, I., Mohan, U., and McNaughton, B. R. (2013) A protein transduction domain with cell uptake and selectivity profiles that are controlled by multivalency effects Chem. Biol. 20, 434 - 444
41. DePorter, S. M., Lui, I., Bruce, V. J., Gray, M. A., Lopez-Islas, M., and McNaughton, B. R. (2014) Mutagenesis modulates the uptake efficiency, cell-selectivity, and functional enzyme delivery of a protein transduction domain Mol. Biosyst. 10, 18 - 23
42. Smith, B. A., Daniels, D. S., Coplin, A. E., Jordan, G. E., McGregor, L. M., and Schepartz, A. (2008) Minimally cationic cell-permeable miniature proteins via alpha-helical arginine display J. Am. Chem. Soc. 130, 2948 - 2949
43. Kelly, K. A., Waterman, P., and Weissleder, R. (2006) In vivo imaging of molecularly targeted phage Neoplasia 8, 1011 - 8
44. Kim, D. S., Jeon, S. E., and Park, K. C. (2004) Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells Cell. Signalling 16, 81 - 8
45. Wardman, P. (2002) Indole-3-acetic acids and horseradish peroxidase: a new prodrug/enzyme combination for targeted cancer therapy Curr. Pharm. Des. 8, 1363 - 74
46. Yan, M., Du, J., Gu, Z., Liang, M., Hu, Y., Zhang, W., Priceman, S., Wu, L., Zhou, Z. H., Liu, Z., Segura, T., Tang, Y., and Lu, Y. (2010) A novel intracellular protein delivery platform based on single-protein nanocapsules Nat. Nanotechnol. 5, 48 - 53